ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,937.81
-0.21%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Xeris Biopharma Holdings Inc (XERS)

  7. Xeris Biopharma Holdings Inc (XERS) Noticias

XERS

Xeris Biopharma (XERS)

Xeris Biopharma Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XERS
FechaHoraFuenteTítuloSímboloCompañía
09/05/202406:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
09/05/202406:00Business WireXeris Biopharma Reports First Quarter 2024 Financial Results and Recent EventsNASDAQ:XERSXeris Biopharma Holdings Inc
06/05/202406:00Business WireXeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta BionicsNASDAQ:XERSXeris Biopharma Holdings Inc
02/05/202406:00Business WireXeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:XERSXeris Biopharma Holdings Inc
03/04/202415:05Business WireXeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:XERSXeris Biopharma Holdings Inc
02/04/202406:00Business WireXeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:XERSXeris Biopharma Holdings Inc
06/03/202415:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XERSXeris Biopharma Holdings Inc
06/03/202415:10Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:XERSXeris Biopharma Holdings Inc
06/03/202406:02Business WireXeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent EventsNASDAQ:XERSXeris Biopharma Holdings Inc
06/03/202406:00Business WireXeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin CapitalNASDAQ:XERSXeris Biopharma Holdings Inc
28/02/202406:00Business WireXeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024NASDAQ:XERSXeris Biopharma Holdings Inc
05/02/202406:00Business WireXeris to Present at the Oppenheimer 34th Annual Healthcare Life Science ConferenceNASDAQ:XERSXeris Biopharma Holdings Inc
31/01/202416:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XERSXeris Biopharma Holdings Inc
10/01/202409:12Dow Jones NewsXeris Biopharma Shares Climb 12% on Amgen License AgreementNASDAQ:XERSXeris Biopharma Holdings Inc
10/01/202407:53Dow Jones NewsXeris Biopharma Reaches License Agreement With Amgen On Thyroid Eye Disease TreatmentNASDAQ:XERSXeris Biopharma Holdings Inc
10/01/202407:00Business WireXeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of TeprotumumabNASDAQ:XERSXeris Biopharma Holdings Inc
04/01/202406:00Business WireXeris Biopharma Updates Its Outlook for 2023NASDAQ:XERSXeris Biopharma Holdings Inc
27/12/202306:00Business WireXeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:XERSXeris Biopharma Holdings Inc
09/11/202315:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XERSXeris Biopharma Holdings Inc
09/11/202306:00Business WireXeris Biopharma Reports Third Quarter 2023 Financial ResultsNASDAQ:XERSXeris Biopharma Holdings Inc
16/10/202306:00Business WireXeris Biopharma Raises Full-Year Financial Guidance and Reaffirms Cash Flow Breakeven in Q4 2023NASDAQ:XERSXeris Biopharma Holdings Inc
27/09/202307:00Business WireXeris Biopharma Announces Private Convertible Note Exchange TransactionsNASDAQ:XERSXeris Biopharma Holdings Inc
14/09/202315:05Business WireXeris to Participate in the 2023 Cantor Global Healthcare ConferenceNASDAQ:XERSXeris Biopharma Holdings Inc
28/08/202306:00Business WireXeris to Participate at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:XERSXeris Biopharma Holdings Inc
08/08/202306:00Business WireXeris Biopharma Reports Second Quarter 2023 Financial ResultsNASDAQ:XERSXeris Biopharma Holdings Inc
01/08/202306:00Business WireXeris Biopharma to Report Second Quarter 2023 Financial Results on August 8, 2023NASDAQ:XERSXeris Biopharma Holdings Inc
31/07/202306:00Business WireXeris Ships One Millionth Gvoke® UnitNASDAQ:XERSXeris Biopharma Holdings Inc
21/06/202306:00Business WireXeris Biopharma Announces First Participant Dosed in a Phase 2 Clinical Study of Its Investigational Subcutaneous (SC) Levothyroxine (XP-8121) in Patients With HypothyroidismNASDAQ:XERSXeris Biopharma Holdings Inc
07/06/202316:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XERSXeris Biopharma Holdings Inc
01/06/202306:00Business WireXeris Biopharma to Participate at the Jefferies Healthcare ConferenceNASDAQ:XERSXeris Biopharma Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:XERS

Su Consulta Reciente

COIN
XOVBTC
XOVBank
AMEX
FLYD
Microsectors Travel 3x I...
NASDAQ
WCMOX
WCM Focused Internationa...
NYSE
ECCW
Eagle Point Credit
LSE
WTRE
Wt Wtre Acc
AMEX
NRSH
Aztlan North America Nea...
USOTC
PRXM
Proxim Wireless (CE)
COIN
TACETH
COIN
QUANTETH
QUANT
POLO
GODSUSDT
Gods Unchained
LSE
XDEB
Xworld Minvol
BOV
OFSA3Q
OUROFINO S/A ON
LSE
WTAI
Wi Ai Ucits Etf
LSE
ZT92
Roy.bk.can.28
USOTC
EMSBD
JP Morgan ETFs Ireland I... (GM)
NASDAQ
UTVGX
Growth Index Investment ...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados